News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
811,723 Results
Type
Article (53858)
Company Profile (386)
Press Release (757451)
Multimedia
Podcasts (154)
Webinars (22)
Section
Business (225902)
Career Advice (2565)
Deals (38273)
Drug Delivery (156)
Drug Development (87550)
Employer Resources (196)
FDA (17797)
Job Trends (16472)
News (380158)
Policy (36634)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2985)
Accelerated approval (51)
Adcomms (36)
Allergies (185)
Alliances (53851)
ALS (224)
Alzheimer's disease (1935)
Antibody-drug conjugate (ADC) (499)
Approvals (18119)
Artificial intelligence (773)
Autoimmune disease (322)
Automation (58)
Bankruptcy (389)
Best Places to Work (12546)
BIOSECURE Act (23)
Biosimilars (239)
Biotechnology (247)
Bladder cancer (205)
Brain cancer (80)
Breast cancer (797)
Cancer (6207)
Cardiovascular disease (533)
Career advice (2156)
Career pathing (42)
CAR-T (362)
CDC (69)
Celiac Disease (3)
Cell therapy (1000)
Cervical cancer (49)
Clinical research (75489)
Collaboration (2266)
Company closure (7)
Compensation (1451)
Complete response letters (100)
COVID-19 (2955)
CRISPR (118)
C-suite (1225)
Cystic fibrosis (162)
Data (8179)
Decentralized trials (3)
Denatured (43)
Depression (186)
Dermatology (90)
Diabetes (630)
Diagnostics (7487)
Digital health (60)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (372)
Drug pricing (234)
Drug shortages (36)
Duchenne muscular dystrophy (304)
Earnings (102076)
Editorial (74)
Employer branding (24)
Employer resources (163)
Events (135894)
Executive appointments (1166)
FDA (21688)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1857)
Gene editing (259)
Generative AI (71)
Gene therapy (820)
GLP-1 (1222)
Government (5454)
Grass and pollen (8)
Guidances (413)
Healthcare (21039)
HIV (89)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (102)
Immunology and inflammation (346)
Immuno-oncology (103)
Indications (196)
Infectious disease (3329)
Inflammatory bowel disease (239)
Inflation Reduction Act (15)
Influenza (146)
Intellectual property (303)
Interviews (435)
IPO (17711)
IRA (57)
Job creations (4249)
Job search strategy (1802)
JPM (71)
Kidney cancer (21)
Labor market (112)
Layoffs (664)
Leadership (42)
Legal (9039)
Liver cancer (108)
Longevity (34)
Lung cancer (811)
Lymphoma (440)
Machine learning (64)
Management (62)
Manufacturing (1138)
MASH (207)
Medical device (15105)
Medtech (15237)
Mergers & acquisitions (21843)
Metabolic disorders (1672)
mRNA (242)
Multiple sclerosis (198)
NASH (23)
Neurodegenerative disease (468)
Neuropsychiatric disorders (122)
Neuroscience (3582)
Neurotech (1)
NextGen: Class of 2026 (7388)
Non-profit (5117)
Now hiring (79)
Obesity (808)
Opinion (344)
Ovarian cancer (230)
Pain (277)
Pancreatic cancer (320)
Parkinson's disease (392)
Partnered (34)
Patents (625)
Patient recruitment (708)
Peanut (67)
People (64931)
Pharmaceutical (76)
Pharmacy benefit managers (35)
Phase 1 (23538)
Phase 2 (33129)
Phase 3 (24769)
Pipeline (9102)
Policy (368)
Postmarket research (2827)
Preclinical (10226)
Press Release (72)
Prostate cancer (323)
Psychedelics (64)
Radiopharmaceuticals (355)
Rare diseases (1198)
Real estate (6715)
Recruiting (78)
Regulatory (27934)
Reports (71)
Research institute (2703)
Resumes & cover letters (435)
Rett syndrome (39)
RNA editing (24)
RSV (98)
Schizophrenia (190)
Series A (315)
Series B (228)
Service/supplier (15)
Sickle cell disease (121)
Special edition (32)
Spinal muscular atrophy (181)
Sponsored (51)
Startups (4032)
State (2)
Stomach cancer (21)
Supply chain (137)
Tariffs (95)
The Weekly (108)
Vaccines (1238)
Venture capital (120)
Weight loss (549)
Women's health (132)
Worklife (23)
Date
Today (142)
Last 7 days (811)
Last 30 days (3786)
Last 365 days (32475)
2026 (13738)
2025 (32703)
2024 (37648)
2023 (42513)
2022 (53800)
2021 (58578)
2020 (57555)
2019 (51140)
2018 (38692)
2017 (35344)
2016 (35476)
2015 (41542)
2014 (35747)
2013 (30726)
2012 (32716)
2011 (33384)
2010 (31940)
Location
Africa (920)
Alabama (102)
Alaska (7)
Arizona (378)
Arkansas (16)
Asia (47001)
Australia (7836)
California (13804)
Canada (3866)
China (1452)
Colorado (591)
Connecticut (608)
Delaware (423)
Europe (105900)
Florida (2064)
Georgia (453)
Hawaii (3)
Idaho (67)
Illinois (1147)
India (96)
Indiana (636)
Iowa (24)
Japan (558)
Kansas (139)
Kentucky (56)
Louisiana (44)
Maine (89)
Maryland (1683)
Massachusetts (10051)
Michigan (402)
Minnesota (767)
Mississippi (7)
Missouri (159)
Montana (37)
Nebraska (30)
Nevada (150)
New Hampshire (91)
New Jersey (3684)
New Mexico (33)
New York (3633)
North Carolina (1850)
North Dakota (11)
Northern California (6876)
Ohio (431)
Oklahoma (26)
Oregon (47)
Pennsylvania (2748)
Puerto Rico (30)
Rhode Island (51)
South America (1333)
South Carolina (88)
South Dakota (2)
Southern California (5446)
Tennessee (219)
Texas (2220)
United States (49349)
Utah (416)
Vermont (1)
Virginia (349)
Washington D.C. (84)
Washington State (1119)
West Virginia (4)
Wisconsin (149)
Wyoming (2)
811,723 Results for "20 20 genesystems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Postmarket research
Amgen’s rare disease drug Tavneos tied to 20 deaths in Japan
The FDA has previously linked eight deaths in the U.S. to Tavneos and has alleged that doctored data were used to support its 2021 approval.
May 18, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Apollomics Inc. Announces $2.0 Million Bridge Financing
April 1, 2026
·
4 min read
Press Releases
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
April 7, 2026
·
5 min read
Press Releases
Emergent BioSolutions to Participate in Upcoming Investor Conferences - May 20, 2026
May 20, 2026
·
1 min read
Press Releases
Syndax Announces Participation in Upcoming Investor Conferences - May 20, 2026
May 20, 2026
·
1 min read
Press Releases
C4 Therapeutics to Participate in Upcoming Conferences - May 20, 2026
May 20, 2026
·
1 min read
Press Releases
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences - May 20, 2026
May 20, 2026
·
1 min read
Press Releases
Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress
May 12, 2026
·
11 min read
Press Releases
Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes
April 15, 2026
·
7 min read
Press Releases
Humacyte, Inc. Announces Pricing of $20 Million Registered Direct Offering of Common Stock
March 19, 2026
·
7 min read
1 of 81,173
Next
